KENNETH L. WAGGONER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

PharmaCyte Biotech, Inc.

Filing Date Source Excerpt
2023-06-05 Kenneth L. Waggoner (6) 35,000 * Includes 12,000 shares issuable upon the exercise of options to purchase common stock and 23,000 shares upon the vesting of restricted stock units. Mr. Waggoner resigned from all positions with the Company effective October 6, 2022.
2023-07-31 Kenneth L. Waggoner - Director, includes 12,000 shares issuable upon the exercise of options to purchase common stock and 23,000 shares upon the vesting of restricted stock units.

Data sourced from SEC filings. Last updated: 2026-02-03